Article
Nuclear Receptor RORα/γ: Exciting Modulators in Metabolic Syndrome and Related Disorders
21 Jun 2022
Abstract excerpt
Under the influences of modern lifestyle, metabolic syndromes (MetS), including insulin resistance, obesity, and fatty liver, featuring a worldwide chronic disease, greatly raise the risk of type 2 diabetes, heart disease, and stroke. However, its pathogenesis is still unclear, and there are limited drugs with strong clinical efficacy and specificity. Given the close connection between impaired lipid metabolism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
